Institutional Investors Trade Moderna Shares Amid Stock Activity
1 report, 1 independent
Updated Tue 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
During the second quarter, several firms acquired new positions in Moderna shares, including BlackRock Inc. and Theleme Partners LLP. Wellington Management Group LLP increased its stake by 4.4% during the same period. In the third quarter, Contravisory Investment Management Inc. reduced its holdings in Moderna by 37.9% after selling 9,168 shares.
From tickerreport.com
Why it matters
The varying buying and selling activity by large institutional investors reflects shifting market sentiment regarding Moderna. This investment flow can influence the company's market valuation and future capital availability.
From tickerreport.com
Who's involved
- ModernaAmerican biotechnology company whose stock was subject to institutional trading
- Merck KGaAPartner of Moderna in developing personalized mRNA cancer vaccines
- MerckPartner of Moderna in developing personalized mRNA cancer vaccines
Keep exploring
The entities involved
-
Moderna
American biotechnology company